PROTAGONIST THERAPEUTICS Trademark
Trademark Overview
On Friday, March 3, 2023, a trademark application was filed for PROTAGONIST THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PROTAGONIST THERAPEUTICS trademark a serial number of 97822178. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, April 15, 2025. This trademark is owned by PROTAGONIST THERAPEUTICS, INC.. The PROTAGONIST THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of metabolic disorders
Providing healthcare information to healthcare professionals and patients relating to disease states and treatment options; Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders
Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders; Scientific research, pharmaceutical research, medical research; technical consultation services in the field of research and product development for the treatment of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; scientific consultation services in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; product development services for others in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; research and development of new products pertaining to the treatment of immune mediated diseases, inflammatory diseases, oncological and rare diseases
General Information
| Serial Number | 97822178 |
| Word Mark | PROTAGONIST THERAPEUTICS |
| Filing Date | Friday, March 3, 2023 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Tuesday, April 15, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 29, 2023 |
Trademark Statements
| Goods and Services | Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of metabolic disorders |
| Goods and Services | Providing healthcare information to healthcare professionals and patients relating to disease states and treatment options; Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders; Scientific research, pharmaceutical research, medical research; technical consultation services in the field of research and product development for the treatment of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; scientific consultation services in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; product development services for others in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; research and development of new products pertaining to the treatment of immune mediated diseases, inflammatory diseases, oncological and rare diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 23, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 23, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, August 22, 2006 |
| First Use In Commerce Date | Tuesday, August 22, 2006 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 23, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | PROTAGONIST THERAPEUTICS, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
| Party Name | PROTAGONIST THERAPEUTICS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
Trademark Events
| Event Date | Event Description |
| Tuesday, March 7, 2023 | NEW APPLICATION ENTERED |
| Thursday, March 23, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, June 25, 2023 | ASSIGNED TO EXAMINER |
| Monday, July 3, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, July 3, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 18, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 3, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, July 17, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 17, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 20, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 29, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, August 9, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 29, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 24, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, March 13, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, March 12, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, March 12, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, March 12, 2024 | SOU EXTENSION 1 FILED |
| Friday, October 11, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, October 11, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, October 11, 2024 | SOU EXTENSION 2 FILED |
| Friday, October 11, 2024 | SOU EXTENSION 2 GRANTED |
| Tuesday, April 15, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, April 15, 2025 | SOU EXTENSION 3 FILED |
| Tuesday, April 15, 2025 | SOU EXTENSION 3 GRANTED |
| Wednesday, April 16, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
